Semaglutide May Reduce Anxiety and Depression by Calming Brain Inflammation | Research

The takeaway

In diabetic animals, semaglutide reduced anxiety and depression by modulating neuroinflammation pathways in the prefrontal cortex.

4 brain markers
GFAP, NEFL, NSE, and GAL3 were modulated by semaglutide in the prefrontal cortex

What the researchers found

Semaglutide reduced anxiety and depression in diabetic animal models by modulating the kynurenine pathway and neurobiological markers in the prefrontal cortex.

Why it matters

If semaglutide can protect the brain from inflammation-driven mood disorders, it could offer dual benefits for the millions with both diabetes and depression.

The numbers in context

Evaluated kynurenine pathway and neurobiological markers (GFAP, NEFL, NSE, GAL3) in prefrontal cortex. Also measured peripheral inflammation and stress parameters.

How the study worked

Animal model study (diabetic mice) examining behavioral outcomes and neurobiological markers in the prefrontal cortex.

Who was studied

Diabetic rats

What this study cannot tell us

Animal study — results may not directly translate to humans. The prefrontal cortex was the only brain region examined.

How to read the evidence

Preclinical animal study — provides mechanistic insight but requires human clinical trials to confirm relevance.

When this study was published

Published in 2025, part of an accelerating wave of research on GLP-1 drugs and brain health.

The bigger picture

This adds to growing evidence that GLP-1 drugs have meaningful effects on the brain, potentially expanding their use into neuropsychiatric conditions.

Questions still open

Do these neuroprotective effects occur at standard diabetes doses of semaglutide?
Would similar benefits be seen in non-diabetic individuals with mood disorders?

Common questions

Can semaglutide help with depression?

Animal studies suggest it may reduce depression by calming brain inflammation, but human clinical trials are needed to confirm this effect.

How does diabetes cause mood problems?

Diabetes triggers chronic inflammation that affects the brain, particularly through the kynurenine pathway, which can promote anxiety and depression.

Read the original research

Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.

Cellular and molecular neurobiology, 45(1), 22

View on PubMed ↗Publisher’s paper ↗

Citation

Piątkowska-Chmiel, Iwona; Wicha-Komsta, Katarzyna; Pawłowski, Kamil; Syrytczyk, Aleksandra; Kocki, Tomasz; Dudka, Jarosław; Herbet, Mariola. (2025). Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.. Cellular and molecular neurobiology, 45(1), 22. https://doi.org/10.1007/s10571-025-01534-4